Skip to main content
Premium Trial:

Request an Annual Quote

'Nutraceutical' Shop Wellgen Pockets $9.5M in VC Cash for Staff Expansion, Other Needs

NEW YORK (GenomeWeb News) - WellGen has taken in $9.5 million in a Series C round of venture-capital financing from new and existing shareholders, the company said Monday.
The nutrigenomics company said it plans to use the cash to hire new personnel and expand its "molecular biology and natural products chemistry laboratory."
It also plans to develop an anti-obesity ingredient used in foods and conduct further studies of WG0401, an enriched extract from black tea that the company said has "demonstrated inflammation-fighting properties in multiple studies in humans."

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.